Whole-body FDG-PET unravels puzzling fevers
Whole-body FDG-PET can reveal the cause of fevers of unknown origin, according to Dutch researchers.
Whole-body FDG-PET can reveal the cause of fevers of unknown origin, according to Dutch researchers.
Dr. W.J. Oyen, a nuclear physician at Nijmegen Medical Center, and colleagues drew 75 patients from one university and five general community hospitals with fevers of at least 100.4 degrees F that had persisted for at least three weeks. They performed PET after chest x-ray, abdominal ultrasound, and a cryoglobulin blood test failed to identify the fevers' origins.
PET was clinically helpful in 70% of the cases, in which it produced a positive result, and it contributed to the ultimate diagnosis in 33%. Clinicians can boost the efficacy of FDG-PET by excluding patients with a normal erythrocyte sedimentation rate or C-reactive protein. Positive PET findings never arose under those conditions, the researchers said. Oyen reported the findings at the 2006 Society of Nuclear Medicine meeting.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.
